Articles tagged as: Eli Lilly and Co.
January 5, 2024
Eli Lilly launches telehealth service, will ship some medication directly to patients
The LillyDirect website connects people with independent telehealth providers, tailored support and other disease management resources. The website also allows patients to have some medications delivered directly to their home.
Read MoreNovember 8, 2023
FDA approves new version of diabetes drug Mounjaro for weight loss
Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.
Read MoreApril 19, 2023
Ivy Tech and Eli Lilly launch biopharmaceutical manufacturing scholarship program
The ‘Lilly Scholars @ Ivy Tech' program will build on Ivy Tech’s existing biopharmaceutical manufacturing certification program. Eli Lilly will fund the $15 million project for the next five years.
Read MoreMarch 1, 2023
Eli Lilly announces new insulin price caps, advocates hope other manufacturers follow suit
The Indianapolis-based pharmaceutical company, Eli Lilly and Company, announced Wednesday it will lower the prices of its branded insulin by 70 percent and will introduce more price caps for its non-branded insulin.
Read MoreMarch 1, 2023
Lilly plans to slash some insulin prices, expand cost cap
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions.
Read MoreJanuary 20, 2023
Lilly shares slip as FDA seeks more Alzheimer's drug data
Eli Lilly shares slipped Friday after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment.
Read MoreNovember 20, 2022
As state moves forward with Lebanon industrial district, some worry “they don’t have a clear plan”
Efforts are underway to build a massive, multi-billion dollar research and industrial park near Lebanon, Indiana. But as the project has grown, questions are being raised by both residents and the leaders of neighboring cities about what the project will look like - and what kind of resources it will require.
Read MoreOctober 24, 2022
Advocacy groups call on Eli Lilly to reduce insulin prices: 'Stop the greed and do what is right'
T1International, an advocacy group for type 1 diabetics, is calling on pharmaceutical companies like Eli Lilly to lower their insulin prices. The group has been pushing these efforts in Indianapolis for several years.
Read MoreSeptember 29, 2022
Feds allege age-based hiring discrimination at Lilly in lawsuit
The U.S. Equal Employment Opportunity Commission alleges Lilly's managers changed practices to hire more young employees, including requiring higher levels of review and approval for older applicants, through at least 2021. The commission says managers knew these practices constituted unlawful age discrimination, but continued them anyway.
Read MoreSeptember 15, 2022
Is Indiana's abortion law bad for business?
In many ways, pregnant people, hospitals, and OB-GYNs will immediately experience the effects of Indiana's new abortion restrictions. The timeline for economic repercussions is less clear after the law goes into effect Sept. 15.
Read More